Efficacy of RAD001 (everolimus) and octreotide LAR in advanced low- to intermediate-grade neuroendocrine tumors: results of a phase II study (Q37121673)

From Wikidata
Jump to navigation Jump to search
scientific article published on September 2008
edit
Language Label Description Also known as
English
Efficacy of RAD001 (everolimus) and octreotide LAR in advanced low- to intermediate-grade neuroendocrine tumors: results of a phase II study
scientific article published on September 2008

    Statements

    Efficacy of RAD001 (everolimus) and octreotide LAR in advanced low- to intermediate-grade neuroendocrine tumors: results of a phase II study (English)
    James C Yao
    Alexandria T Phan
    David Z Chang
    Robert A Wolff
    Kenneth Hess
    Sanjay Gupta
    Carmen Jacobs
    Jeannette E Mares
    Andrea N Landgraf
    Asif Rashid
    1 September 2008
    4311-4318

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit